Therapeutic Modulation of the Gut Microbiome by Supplementation with Probiotics (SCI Microbiome Mix) in Adults with Functional Bowel Disorders: A Randomized, Double-Blind, Placebo-Controlled Trial
Microorganisms · 30.09.2025 · 13 (10) · 2283
DOI: 10.3390/microorganisms13102283 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 30.09.2025. Verfasst von Won Yeong Bang und 8 weiteren Autor:innen. Beteiligte Einrichtung: ILDONG Bioscience, Pyeongtaek-si 17957, Republic of Korea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Ildong Bioscience.
Abstract (Originalsprache)
Functional bowel disorders (FBDs) are chronic gastrointestinal conditions characterized by recurrent symptoms associated with gut microbiota dysbiosis. Although accumulating evidence suggests that probiotics can improve symptoms in patients with FBD, the underlying mechanisms remain to be fully elucidated. In this randomized, double-blind, placebo-controlled clinical trial, 38 adults meeting the Rome IV diagnostic criteria of functional constipation (FC) and functional diarrhea (FD) received either a multi-strain probiotic complex or placebo for 8 weeks. Clinical outcomes were evaluated using the Irritable Bowel Syndrome Severity Scoring System (IBS-SSS), bowel habits questionnaire, and IBS Quality of Life (IBS-QoL) instrument. Fecal samples were collected at baseline and at week 8 for gut microbiota profiling via 16S rRNA gene sequencing and metabolomic analysis using gas chromatography–mass spectrometry. Probiotic supplementation significantly reduced the severity of abdominal bloating and its interference with quality of life, and improved the body image domain of the IBS-QoL. Beta diversity analysis showed significant temporal shifts in the probiotic group, while 16S rRNA sequencing revealed an increased relative abundance of Faecalibacterium prausnitzii and Blautia stercoris. Fecal metabolomic analysis further indicated elevated levels of metabolites implicated in the gut–brain axis. Multi-strain probiotic supplementation alleviated gastrointestinal symptoms and improved aspects of psychosocial well-being in adults with FBDs, potentially through modulation of the human gut microbiome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ILDONG Bioscience, Pyeongtaek-si 17957, Republic of Korea.
- Department of Microbiology, College of Medicine, Inha University, Incheon 22212, Republic of Korea.
- School of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Republic of Korea.
- Division of Gastroenterology, Department of Internal Medicine, Inha University Hospital, Incheon 22212, Republic of Korea.
- Department of Microbiology, College of Medicine, Dongguk University, 123 Dongdae-ro, Gyeongju 38066, Republic of Korea.
ORCID-Profile: Won Yeong Bang, Jin Seok Moon, Young Hoon Jung, Jungwoo Yang
Förderung
- Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries
- Ildong Bioscience
Zitieren
APA
Bang, W. Y., Moon, J. S., Kim, H., Lee, H. B., Kim, D., Shin, M., Jung, Y. H., Shin, J., & Yang, J. (2025). Therapeutic Modulation of the Gut Microbiome by Supplementation with Probiotics (SCI Microbiome Mix) in Adults with Functional Bowel Disorders: A Randomized, Double-Blind, Placebo-Controlled Trial. Microorganisms, 13(10), 2283. https://doi.org/10.3390/microorganisms13102283
Vancouver
Bang WY, Moon JS, Kim H, Lee HB, Kim D, Shin M, et al. Therapeutic Modulation of the Gut Microbiome by Supplementation with Probiotics (SCI Microbiome Mix) in Adults with Functional Bowel Disorders: A Randomized, Double-Blind, Placebo-Controlled Trial. Microorganisms. 2025;13(10):2283. doi:10.3390/microorganisms13102283
BibTeX
@article{Bang2025,
author = {Bang, Won Yeong and Moon, Jin Seok and Kim, Hayoung and Lee, Han Bin and Kim, Donggyu and Shin, Minhye and Jung, Young Hoon and Shin, Jongbeom and Yang, Jungwoo},
title = {Therapeutic Modulation of the Gut Microbiome by Supplementation with Probiotics (SCI Microbiome Mix) in Adults with Functional Bowel Disorders: A Randomized, Double-Blind, Placebo-Controlled Trial},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {10},
pages = {2283},
doi = {10.3390/microorganisms13102283}
}
EUVIMED